Table 3 Adverse effects of C7 and event during the study.

From: Maximum dose, safety, tolerability and ketonemia after triheptanoin in glucose transporter type 1 deficiency (G1D)

 

Grade 1–2 n (%)

Grade 3 n (%)

Adverse effects

Emesis

5 (60%)

1 (8%)

Nausea

1 (8%)

 

Diarrhea

6 (50%)

 

Abdominal discomfort

2 (17%)

1 (8%)

Neurological event

Seizure

1 (8%)

 
  1. Effects in group B subjects were graded from 1 to 3 using Common Toxicity Criteria. N: number of subjects. The seizure was judged unrelated to C7 based on previous event pattern in this subject.
Back to article page